Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Dissecting the higher-order regulatory networks controlling alternative splicing in lung cancer
EF 2017-18
Résumé
Despite large advances in cancer research over the past few decades, there are still ~8 million cancer-related deaths globally every year. The complexity of treating cancer arises from the vast heterogeneity in tumor-promoting biological pathways between and within patients, which inevitably precludes the discovery of a universal cure. Among the pathways harnessed by cancer, alternative splicing (AS) is particularly interesting. As a developmentally important process, AS largely contributes to the biological intricacies of complex organisms such as ourselves. The high prevalence and complexity of AS in humans is a major reason why the cells of our body are observably very different from each other while containing the same DNA. It has been widely established that AS is altered in cancer, influencing numerous features of cancer biology, such as uncontrolled proliferation and resistance of cancer cells to chemotherapy. However, there is a lack of understanding in the origin of cancerous AS alterations–what are the DNA mutations that initiate these AS changes? To answer this question, I propose a large-scale screen that allows for the simultaneous analysis of AS alterations in tens of thousands of cells that have lost function in different cancer-related genes. Through AS analyses of patient tumors, I hope to utilize the findings from this project to reveal new targets for cancer diagnosis and therapy.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
386664
Name
Lim Justin J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Dissecting the higher-order regulatory networks controlling alternative splicing in lung cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alternative Splicing; Cancer; Cancer Diagnosis; Cancer Therapy; Crispr; Gene Expression; Genomics; High-Throughput Screen; Personalized Medicine; Rna Sequencing
Abstract
Despite large advances in cancer research over the past few decades, there are still ~8 million cancer-related deaths globally every year. The complexity of treating cancer arises from the vast heterogeneity in tumor-promoting biological pathways between and within patients, which inevitably precludes the discovery of a universal cure. Among the pathways harnessed by cancer, alternative splicing (AS) is particularly interesting. As a developmentally important process, AS largely contributes to the biological intricacies of complex organisms such as ourselves. The high prevalence and complexity of AS in humans is a major reason why the cells of our body are observably very different from each other while containing the same DNA. It has been widely established that AS is altered in cancer, influencing numerous features of cancer biology, such as uncontrolled proliferation and resistance of cancer cells to chemotherapy. However, there is a lack of understanding in the origin of cancerous AS alterations–what are the DNA mutations that initiate these AS changes? To answer this question, I propose a large-scale screen that allows for the simultaneous analysis of AS alterations in tens of thousands of cells that have lost function in different cancer-related genes. Through AS analyses of patient tumors, I hope to utilize the findings from this project to reveal new targets for cancer diagnosis and therapy.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lim, Justin J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~